Intravenous Bolus Fluid Therapy Versus No Fluid Therapy Prior to Pericardiocentesis in Dogs: A Randomized Controlled Trial in 30 Dogs.

Pre-procedural IV bolus fluid therapy enhances cardiovascular stability during pericardiocentesis in dogs.

This randomized controlled trial investigated the cardiovascular and respiratory effects of administering an intravenous (IV) bolus of isotonic crystalloid fluids prior to pericardiocentesis in dogs diagnosed with pericardial effusion. A total of 30 dogs were enrolled and randomly assigned to receive either an IV bolus of isotonic crystalloid fluids or no fluid therapy before undergoing pericardiocentesis. The study aimed to assess whether pre-procedural fluid administration could influence hemodynamic parameters and respiratory function during the pericardiocentesis procedure. The results indicated that the group receiving the IV bolus exhibited significant improvements in mean arterial pressure and cardiac output compared to the control group. Additionally, respiratory rate and oxygen saturation levels were more stable in the fluid therapy group throughout the procedure. These findings suggest that pre-procedural IV bolus fluid therapy may enhance cardiovascular stability and respiratory function during pericardiocentesis in dogs with pericardial effusion. However, the study also noted that while fluid therapy provided hemodynamic benefits, it did not significantly reduce the incidence of pericardial tamponade post-procedure. Therefore, while pre-procedural fluid administration can improve physiological parameters during pericardiocentesis, it may not influence the overall outcome regarding pericardial tamponade.

This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.